Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Iprivask (Desirudin) Injection
Company:  Aventis Pharmaceuticals, Inc.
Application No.:  021271
Approval Date: 4/04/2003


Date created: November 152004

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.